ADALUZIS Trademark

Trademark Overview

On Wednesday, March 13, 2013, a trademark application was filed for ADALUZIS with the United States Patent and Trademark Office. The USPTO has given the ADALUZIS trademark a serial number of 79128305. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, March 14, 2023. This trademark is owned by Basilea Pharmaceutica AG. The ADALUZIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, for the treatment of dermatological disorders, for the treatment of oncological diseases, for the treatment of gastrointestinal diseases, for the treatment of neurological diseases, for the treatment of cardiovascular diseases, and for the treatment of gynecological diseases
adaluzis

General Information

Serial Number79128305
Word MarkADALUZIS
Filing DateWednesday, March 13, 2013
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateTuesday, March 14, 2023
Registration Number4523828
Registration DateTuesday, May 6, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 18, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, for the treatment of dermatological disorders, for the treatment of oncological diseases, for the treatment of gastrointestinal diseases, for the treatment of neurological diseases, for the treatment of cardiovascular diseases, and for the treatment of gynecological diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateSunday, December 6, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBasilea Pharmaceutica AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH
Party NameBasilea Pharmaceutica AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH
Party NameBasilea Pharmaceutica AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events

Event DateEvent Description
Monday, October 2, 2023NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Monday, October 2, 2023DEATH OF INTERNATIONAL REGISTRATION
Saturday, August 27, 2022CHANGE OF NAME/ADDRESS REC'D FROM IB
Sunday, September 19, 2021TOTAL INVALIDATION PROCESSED BY THE IB
Tuesday, August 17, 2021TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Tuesday, August 17, 2021INVALIDATION PROCESSED
Friday, August 6, 2021TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Sunday, December 6, 2020CANCELLED SECTION 71
Sunday, December 6, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, February 9, 2018NEW REPRESENTATIVE AT IB RECEIVED
Thursday, August 13, 2015NEW REPRESENTATIVE AT IB RECEIVED
Thursday, August 6, 2015NEW REPRESENTATIVE AT IB RECEIVED
Friday, October 10, 2014FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, September 24, 2014FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, September 24, 2014FINAL DISPOSITION PROCESSED
Wednesday, August 6, 2014FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, May 6, 2014REGISTERED-PRINCIPAL REGISTER
Tuesday, February 18, 2014NOTIFICATION PROCESSED BY IB
Tuesday, February 18, 2014PUBLISHED FOR OPPOSITION
Wednesday, January 29, 2014NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 29, 2014NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, January 29, 2014NOTICE OF PUBLICATION
Wednesday, January 15, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, January 14, 2014ASSIGNED TO LIE
Tuesday, December 17, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 13, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 12, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 12, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 15, 2013REFUSAL PROCESSED BY IB
Tuesday, June 25, 2013NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, June 25, 2013REFUSAL PROCESSED BY MPU
Tuesday, June 25, 2013NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, June 24, 2013NON-FINAL ACTION WRITTEN
Monday, June 24, 2013ASSIGNED TO EXAMINER
Tuesday, April 30, 2013APPLICATION FILING RECEIPT MAILED
Friday, April 26, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 25, 2013SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

adaluzis treatment diseases gastrointestinal neurological oncological cardiovascular gynecological dermatological preparations substances